Sun Life Financial Inc.

Sun Life Financial and Wilton Re have signed a definitive agreement to form a reinsurance and asset management partnership. Under the agreement, Wilton Re will establish Windsor Life Re, an affiliated reinsurer domiciled in the US and Bermuda, with long-term capital commitments from both parties. The partnership is expected to deploy approximately $900 million in capital, with each party providing about one-third of the total equity capitalization. Windsor Life Re will reinsure an initial in-force block of approximately $1.7 billion from Wilton Re, and future business will be ceded on a quota share basis. At scale, the venture is expected to reach approximately $10 billion in assets. SLC Management, Sun Life's global institutional alternatives asset manager, will serve as lead asset manager for Windsor Life Re's investments. The partnership is scheduled to launch in the first half of 2027, subject to regulatory approvals and customary closing conditions.

Sun Life Financial reported second quarter 2026 results, updated its dividend and buyback activity, and outlined board and executive changes. The company's year-to-date share price return stands at 30.77%, with a one-year total shareholder return of 46.67%. The most followed valuation narrative pegs Sun Life's fair value at about CA$112.93, nearly in line with the last close of CA$112.88. Strong growth across Asian markets, particularly in Individual Protection and wealth products, is expanding Sun Life's addressable market and creating significant new revenue sources, reinforced by double-digit sales and CSM growth in the region year-over-year.

Sun Life Financial Inc. delivered second-quarter 2026 underlying earnings of $1.46 per share, beating the Zacks Consensus Estimate of $1.39 by 5% and rising 13% year over year. Revenues surged 51.9% to $10.09 billion, well above the $6.46 billion consensus, driven by a nearly fourfold jump in net investment income to C$5.52 billion and higher insurance and fee income. Underlying net income rose 11% to C$1.12 billion, with Canada up 23%, the U.S. up 15%, and Asia up 18%. Group insurance sales jumped 27%, individual insurance sales increased 16%, and assets under management rose 10% to C$1.70 trillion. The company maintained a 145% LICAT ratio and reported a 12% increase in total contractual service margin to C$15.3 billion.

Sun Life Financial announced that Joseph Natale will succeed Scott Powers as chair of the Board of Directors following the company's annual meeting on May 5, 2027. Scott Powers will retire as chair and from the Board upon completing his full term of service. Joseph Natale has been a Sun Life director since February 2023 and currently chairs the Management Resource Committee and is a member of the Risk Committee. He previously served as President and CEO of Rogers Communications and TELUS, and is currently lead independent director at Shopify and a senior advisor at Altas Partners.

Sun Life Financial Inc. declared a quarterly common share dividend of $0.96 per share, unchanged from the prior quarter, payable on September 29, 2026 to shareholders of record on August 26, 2026. The board also declared dividends on its Class A Non-Cumulative Preferred Shares, with rates ranging from $0.185438 to $0.283121 per share depending on the series, all payable on the same dates. Common shares acquired under the Canadian Dividend Reinvestment and Share Purchase Plan will be purchased on the open market. The company designated all dividends as eligible dividends for Canadian income tax purposes.

Sun Life U.S. and Claritev are collaborating to bring more efficiency to supplemental health coverage for self-funded employers. Claritev's machine-learning technology reviews medical claims to identify employees eligible for critical illness, accident, and hospital indemnity benefits, enabling Sun Life to proactively notify them and accelerate payments. The solution is available to any self-funded employer offering Sun Life supplemental health coverage, regardless of whether they are a stop-loss client, and is now open for quoting for policies effective January 1, 2027, and later, though it is not available in New York. Sun Life U.S. serves approximately 48 million Americans, while Claritev supports over 750 healthcare payers and more than 100,000 employers.

Sun Life Financial has completed its acquisition of Bell Partners, a leading U.S. multifamily real estate investment manager and vertically integrated property management business. The purchase price was US$350 million, with approximately 80% paid in Sun Life common shares. Bell Partners will continue to operate as a distinct, vertically integrated business under BGO and oversee the broader company's U.S. multifamily assets. The acquisition expands Sun Life's asset management capabilities in one of the largest and most resilient sectors of the U.S. real estate market. Bell Partners will retain its current leadership, property-level branding, office locations, investment vehicles and client focus.

Sun Life Financial, a Toronto-based financial services company, is highlighted as an attractive dividend stock with a current dividend yield of 3.59%, well above the insurance-life insurance industry average of 1.69% and the S&P 500's 1.4%. The company pays a quarterly dividend of $0.71 per share, and its annualized dividend of $2.83 represents a 13% increase from last year. Over the past five years, Sun Life has raised its dividend five times, achieving an average annual increase of 8.94%. With a payout ratio of 50% and a Zacks Consensus Estimate for 2026 earnings of $5.76 per share, implying 8.07% year-over-year growth, the stock carries a Zacks Rank of #2 (Buy).

Sun Life US and Medzown announced a collaboration to increase access to clinical trials for employees of self-insured employers dealing with cancer and complex conditions like orthopedic and musculoskeletal issues. Using Medzown's AI-powered predictive analytics, Sun Life's stop-loss clients can identify members at critical diagnostic stages and connect them with advanced therapeutic options and clinical trials. The partnership aims to address the rising financial burden of high-cost claims, which average over $250,000 for cancer treatments, by providing precision medicine support and personalized patient navigation. A team of scientists and navigators will work directly with members and their care teams, acting as an extension of existing benefits to ensure a supported path to effective, cutting-edge therapies. This initiative expands Sun Life's suite of health solutions, which already includes clinical reviews and expert cancer second opinions, and seeks to improve patient health outcomes while reducing long-term specialty drug cost exposure for self-funded employers.

Sun Life Hong Kong has won 18 awards at the Bloomberg Businessweek Financial Institution Awards 2026, surpassing last year's total of 14. The wins span high-net-worth solutions, cross-border insurance, retirement planning, Mandatory Provident Fund, digital transformation, talent development, bancassurance, and agency force development. First-time wins include Insurance Company of the Year, Annuity Plan, and District Achievement of the Year for agency force, while the company retained International Insurance Company of the Year – Excellence Award and MPF Provider of the Year (Investment Sector) – Excellence Award for the second consecutive year. Chief Executive Officer Clement Lam said the recognition affirms the company's strategic focus on high-net-worth services, retirement planning, and digital innovation.

Traditional retirement income strategies are failing as bond yields have collapsed and Social Security faces a projected shortfall by 2035. The article recommends dividend-paying stocks from low-risk, high-quality companies as an alternative, highlighting OFG Bancorp with a 3.01% yield and 20% annualized dividend growth, Sun Life with a 3.63% yield and 8.54% growth, and Suncor Energy with a 3.09% yield and 3.84% growth. It advises focusing on stocks with yields around 3% and positive dividend growth to combat inflation, while cautioning about high fees in dividend-focused mutual funds and ETFs.